Found 0 matching trials
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC PHASE1 The purpose of this study is to explore the efficacy and safety of toripali...
Show More Location
Hubei Cancer Hospital
Learn More & Join Trial
First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC PHASE2 Our aim in this study was to evaluate the efficacy and safety of etoposide ...
Show More Location
Enze Hospital, affiliated Taizhou Hospital of Wenzhou Medical University
Learn More & Join Trial
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer PHASE2 This is a Phase II/III, randomized, multicenter, open-label clinical trial ...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer PHASE2 Gastric cancer (GC),including cardia and noncardia gastric cancer, is respo...
Show More Location
Shenzhen People's Hospital
Learn More & Join Trial
Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors PHASE2 This is a phase II, single arm, open-label, multicenter study to evaluate t...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study PHASE2 This study is designed to evaluate the efficacy and safety of the combinati...
Show More Location
270 Dongan Road, Fudan University Shanghai Cancer Center
Learn More & Join Trial
Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI PHASE3 This is a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase ...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers PHASE2 This is a single-arm, multicenter, phase 2 study to assess the efficacy and...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma PHASE1 This study will evaluate efficacy and safety of Toripalimab Injection (JS00...
Show More Location
Fudan University Zhongshan Hospital
Learn More & Join Trial
A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer PHASE1 This study is a Phase Ib/II, open-label, multicenter clinical trial. Here, ...
Show More Location
Shanghai East Hospital
Learn More & Join Trial